NASDAQ:ANAC - Anacor Pharmaceuticals Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$99.20 0.00 (0.00 %)
(As of 07/15/2018 04:00 PM ET)
Previous Close$99.20
Today's Range$99.20 - $99.20
52-Week Range$52.00 - $156.93
VolumeN/A
Average Volume1.81 million shs
Market Capitalization$4.50 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.53
Anacor Pharmaceuticals logoAnacor Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. Its lead product development candidate is crisaborole topical ointment, approximately 2%, a non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the treatment of mild-to-moderate atopic dermatitis and psoriasis. Its product, KERYDIN (tavaborole) topical solution, approximately 5%, is an oxaborole antifungal approved by the United States Food and Drug Administration (FDA) for the topical treatment of onychomycosis of the toenails. It also has a pipeline of other internally discovered topical and systemic boron-based compounds in early-stages of research and development, which include AN3365. Its compound, AN5568 (SCYX-7158), is licensed to Drugs for Neglected Diseases initiative (DNDi) for the treatment of human African trypanosomiasis.

Receive ANAC News and Ratings via Email

Sign-up to receive the latest news and ratings for ANAC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryBiotechnology
SectorN/A
SymbolNASDAQ:ANAC
CUSIP03242010
Phone+1-650-5437500

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-92.08%
Return on Equity-133.71%
Return on Assets-38.09%

Miscellaneous

EmployeesN/A
Outstanding Shares44,860,000
Market Cap$4,500.00

The Truth About Cryptocurrencies

Anacor Pharmaceuticals (NASDAQ:ANAC) Frequently Asked Questions

What is Anacor Pharmaceuticals' stock symbol?

Anacor Pharmaceuticals trades on the NASDAQ under the ticker symbol "ANAC."

How were Anacor Pharmaceuticals' earnings last quarter?

Anacor Pharmaceuticals Inc (NASDAQ:ANAC) issued its quarterly earnings data on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.35) by $0.01. The biopharmaceutical company had revenue of $17.54 million for the quarter, compared to analyst estimates of $19.53 million. Anacor Pharmaceuticals had a negative return on equity of 133.71% and a negative net margin of 92.08%. The business's quarterly revenue was up 14.9% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.30) EPS. View Anacor Pharmaceuticals' Earnings History.

What is the consensus analysts' recommendation for Anacor Pharmaceuticals?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anacor Pharmaceuticals in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Has Anacor Pharmaceuticals been receiving favorable news coverage?

News headlines about ANAC stock have trended positive on Sunday, according to Accern. The research firm identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Anacor Pharmaceuticals earned a media sentiment score of 0.28 on Accern's scale. They also gave headlines about the biopharmaceutical company an impact score of 45.74 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Anacor Pharmaceuticals?

Shares of ANAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Anacor Pharmaceuticals' stock price today?

One share of ANAC stock can currently be purchased for approximately $99.20.

How big of a company is Anacor Pharmaceuticals?

Anacor Pharmaceuticals has a market capitalization of $4.50 billion.

How can I contact Anacor Pharmaceuticals?

Anacor Pharmaceuticals' mailing address is 1020 E Meadow Cir, PALO ALTO, CA 94303-4230, United States. The biopharmaceutical company can be reached via phone at +1-650-5437500.


MarketBeat Community Rating for Anacor Pharmaceuticals (NASDAQ ANAC)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  260 (Vote Outperform)
Underperform Votes:  125 (Vote Underperform)
Total Votes:  385
MarketBeat's community ratings are surveys of what our community members think about Anacor Pharmaceuticals and other stocks. Vote "Outperform" if you believe ANAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/15/2018 by MarketBeat.com Staff

Featured Article: What does EPS mean?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.